Antler stem cells as a novel stem cell source for reducing liver fibrosis

• DOI: 10.1007/s00441-019-03081-z
• Publication Date: 2019-08-19T21:43:44Z
• Authors: Xiaoli Rong; Yanyan Yang; Guokun Zhang; Haiying Zhang; Chunyi Li; Yimin Wang
• Keywords: Liver Cirrhosis; Male; 0301 basic medicine; Deer; Stem Cells; Antlers; Mesenchymal Stem Cell Transplantation; Actins; Coculture Techniques; Rats; 3. Good health; Disease Models, Animal; 03 medical and health sciences; Liver; Transforming Growth Factor beta; Proliferating Cell Nuclear Antigen; Hepatic Stellate Cells; Animals; Collagen; Carbon Tetrachloride; Cell Proliferation; Stem Cell Transplantation

Liver fibrosis results from collagen fiber deposition. Antler stem cells (ASCs) naturally in vivo differentiate into cartilage, which is only made of Col II in collagen component; whereas liver fibrosis is caused by over-abundance of Col I and III. In addition, ASCs can effectively promote regenerative wound healing in which tissue contains very few collagen fibers (Col I). In this study, we investigate the therapeutic effects of ASCs in a rat model of CCl4-induced liver fibrosis. Rats were treated with ASCs for 4 weeks in vivo, then biochemical and histopathological analyses were performed. Furthermore, we established cell co-culture systems of hepatic stellate cells (HSCs) and ASCs and of M1 macrophages and ASCs in vitro. Mesenchymal stem cells (MSCs) were used as a positive control. The results showed that ASC transplantation alleviated liver fibrosis effectively as evidenced by reduced collagen accumulation, decreased fatty degeneration, increased hepatocyte regeneration, decreased inflammation and significantly enhanced liver function; moreover, ASCs decreased the expression of pro-fibrogenic factors including TGF-β and α-SMA. Additionally, our study showed that ASCs inhibit HSC activation and proliferation by controlling the expression of MMPs, TIMP1, TGF-β, α-SMA and COL1A2 involved in these processes. Our results suggested that ASCs alleviate liver fibrosis effectively and inhibit HSC activation. Thus, ASCs may serve as a novel stem cell source for the treatment of liver fibrosis in the clinic.